ESMO Open
Health & Wellness Podcasts
ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed Open Access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The journal is published by BMJ on behalf of ESMO. http://esmoopen.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Location:
United States
Genres:
Health & Wellness Podcasts
Description:
ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed Open Access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The journal is published by BMJ on behalf of ESMO. http://esmoopen.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Twitter:
@ESMO_Open
Language:
English
ESMO-Magnitude of Clinical Benefit Scale (V1.1) for early breast cancer therapies
Duración:00:14:58
ESMO-Magnitude of Clinical Benefit Scale of adjuvant colon cancer trials and meta-analyses
Duración:00:07:34
Adjuvant and neoadjuvant therapies in melanoma
Duración:00:12:31
Emerging targets in cancer immunotherapy
Duración:00:07:58
News in breast cancer 2019
Duración:00:13:34
Cancer care during the spread of Covid-19 in Italy: a young oncologist's perspective
Duración:00:10:54
ESMO Presidential Symposium: ClarIDHy - ivosidenib in patients with advanced cholangiocarcinoma
Duración:00:07:00
News on the horizon in glioblastoma therapy
Duración:00:12:12
Highlights in Lung Cancer 2019
Duración:00:26:42
Current biomarkers in immunotherapy
Duración:00:04:46
ESMO Presidential Symposium: Final overall survival analysis from the FLAURA trial
Duración:00:06:30
ESMO Presidential Symposium: Phase III PAOLA-1: Olaparib in newly diagnosed, advanced ovarian cancer
Duración:00:05:39
Reimbursement Reality for Off-label use (OLU) of Drug Treatments in Cancer Care
Duración:00:18:19
The ESMO-Magnitude of Clinical Benefit Scale Group
Duración:00:16:19
What is new on the horizon in Melanoma Brain Metastasis?
Duración:00:07:00
ESMO 2018 Presidential Symposium – IMpassion130: Atezolizumab in triple negative breast cancer
Duración:00:09:10
ESMO 2018 Presidential Symposium: radiotherapy to the primary tumor in metastatic prostate cancer
Duración:00:06:24
The Metastatic Breast Cancer project: a novel patient-partnered initiative
Duración:00:26:53
Biosimilars in oncology
Duración:00:09:49
Tumor evolution in non-small-cell lung cancer
Duración:00:13:42